Insulet | PODD - 贷款资金



金融业
股票价格
USD
资产
USD 3.17B
现金及等价物
USD 534.9M
销售成本
USD 239.1M
流动资产
USD 1.85B
流动负债
USD 744.2M
债务
USD 948.4M
EBIT
USD 129.7M
EBITDA
USD 199.8M
员工
3.9K
EPS每股收益
USD 1.66
股本和储备
USD 1.42B
销售毛利
USD 562.6M
债务利息支出
USD 11M
利息收入
USD 4.9M
贷款资金
USD 929.5M
市值
USD 9.83B
净收入
USD 95M
营业费用
USD 672M
营业利润
USD 129.7M
普通股股本
USD 69.35M
PE价格收益
29.66
税前利润
USD 118.7M
销售收入
USD 801.7M
销售和管理费用
USD 344.8M
股票
USD 484.8M
贸易债权人
USD 123.3M
应收帐款人
USD 588.7M


贷款资金 更改 日
Abbott USD 29.64B 19.74B 2026-03
Align Technology USD 0 0 2024-12
AtriCure USD 61M 0 2026-06
Baxter International USD 8.62B 6M 2026-06
Becton, Dickinson and Co. USD 13.51B 1.2B 2026-06
Boston Scientific USD 10.86B 148M 2026-03
Cardinal Health USD 7B 1.24B 2026-06
Cooper Companies USD 1.92B 54.8M 2026-06
Dexcom USD 1.3B 200K 2026-06
Edwards Lifesciences USD 598.7M 1.3M 2026-06
Eli Lilly USD 47.86B 8.49B 2026-06
Globus Medical USD 398K 38K 2026-03
ICU Medical USD 1.21B 49.38M 2026-06
Inogen USD 0 0 2022-06
Insulet USD 929.5M 0 2026-06
Integra LifeSciences USD 1.83B 2.05M 2026-06
J&J USD 37.34B 183M 2026-06
Medtronic USD 25.62B 502M 2026-06
Merit Medical Systems USD 736.26M 1.1M 2026-06
Roche Holding CHF 25.22B 2.21B 2026-06
Solventum Corp USD 4.57B 2M 2026-06
Stryker USD 14.19B 32M 2026-06
Tandem Diabetes Care USD 602.58M 809K 2026-06
Teleflex USD 2.72B 206.24M 2026-06
West Pharmaceutical Services USD 202.9M 100K 2026-06
Zimmer Biomet Holdings USD 6.28B 17.6M 2026-06